Phosphatidylinositol-3-Kinase/Akt Signaling Pathway and Kidney Cancer, and the Therapeutic Potential of Phosphatidylinositol-3-Kinase/Akt Inhibitors-Reference-Cited by-同舟云学术

Phosphatidylinositol-3-Kinase/Akt Signaling Pathway and Kidney Cancer, and the Therapeutic Potential of Phosphatidylinositol-3-Kinase/Akt Inhibitors

Published:2009-12 Issue:6 Volume:182 Page:2569-2577
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Porta Camillo¹,Figlin Robert A.¹

Affiliation:

1. Medical Oncology and Laboratory of Pre-Clinical Oncology and Developmental Therapeutics, Istituto Di Ricovero e Cura a Carattere Scientifico San Matteo University Hospital Foundation, Pavia, Italy, and Division of Medical Oncology and Experimental Therapeutics, City of Hope National Medical Center/Beckman Research Institute, City of Hope Comprehensive Cancer Center (RAF), Duarte, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference50 articles.

1. Exploiting the PI3K/Akt pathway for cancer drug discovery;Hennessy;Nat Rev Drug Discov,2005

2. Evolving role of novel targeted agents in renal cell carcinoma;Hutson;Oncology (Williston Park),2007

3. Phosphoinositide kinases;Fruman;Annu Rev Biochem,1998

4. PI3K/Akt signalling pathway and cancer;Fresno-Vara;Cancer Treat Rev,2004

5. Protein-protein interactions define specificity in signal transduction;Pawson;Genes Dev,2000

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09

2. N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway;Cell Death & Disease;2024-07-22

3. Kidney toxicology of a novel compound Lithium Bis(trifluoromethanesulfonyl)imide (LiTFSI, ie. HQ-115) used in energy applications: an Epigenetic evaluation;2024-04-03

4. Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma;Cells;2023-12-22

5. Synergistic therapeutic potential of alpelisib in cancers (excluding breast cancer): Preclinical and clinical evidences;Biomedicine & Pharmacotherapy;2023-03